Those materials are ground up, nicotine is extracted from them, and chemicals, fillers, glue, and other agents are added to the slurry. The sheet is then pressed out and puffed, with the previously extracted nicotine sprayed onto it, and ground into tiny curls before being incorporated into cigarettes at the desired level. 7 Tobacco companies have studied nicotine extracts as a method to augment nicotine levels in cigarettes. [8] [9] [10] [11] [12] [13] [14] In addition, tobacco companies have devoted a significant amount of research and development to the use and inclusion of additives in cigarettes, and the industry has acknowledged using 599 different cigarette additives. 15, 16 According to various tobacco company documents, many of these additives are used to improve taste and decrease harshness. 17 We propose that, in contrast, tobacco companies have expended resources to exploit the pharmacological and chemical effects of cigarette additives. The tobacco industry used few additives in US cigarettes before 1970. 18 However, current USstyle cigarettes generally contain about a 10% level of additives according to weight, mostly in the form of sugars, humectants, ammonia compounds, cocoa, and licorice. 19, 20 Most other additives are used in small amounts, less than 0.01% of total weight. There is evidence that the percentage of additives by weight may have increased in the 1990s, especially the use of sweeteners (which many researchers believe were added to entice younger people to smoke). 18 Those increases roughly coincided with the controversial Joe Camel cigarette advertising campaign initiated by RJ Reynolds in 1985. Previous studies have reviewed the use of ammonia technology to increase levels of nicotine and free base nicotine in cigarette smoke 18 ; the use of additives with additional or synergistic addictive potential, anesthetic properties, or bronchodilator effects; and the use of additives that decrease environmental tobacco smoke (ETS) odor, visibility, and irritation without equivalent efforts to decrease the harmful effects of ETS. 18, 21, 22 These tobacco industry practices, motivated by awareness of public concern regarding ETS, may have led to nonsmokers as well as smokers being unaware or less aware of the presence of hazardous substances associated with ETS. [23] [24] [25] [26] [27] In this study, we examined the tobacco industry's use of additives that inhibit nicotine metabolism and increase the addictive potential of cigarettes, with a particular focus on the neurological techniques used by Philip Morris to assess the effects of additives on smokers' central nervous system functioning. We also explored the addition of antioxidants and mitigants to cigarettes in an attempt to prevent illness, genetic modifications of tobacco to increase levels of beta-carotene and incorporate molecules intended to decrease carcinogenic tobaccospecific nitrosamines, the use of other "beneficial" additives and specific chemical additives, and the tobacco industry's objections 17 to scientific discussions 18 about additives used for cigarette engineering and nicotine addiction.
We investigated tobacco industry documents and other sources for evidence of possible pharmacological and chemical effects of tobacco additives.
Our findings indicated that more than 100 of 599 documented cigarette additives have pharmacological actions that camouflage the odor of environmental tobacco smoke emitted from cigarettes, enhance or maintain nicotine delivery, could increase the addictiveness of cigarettes, and mask symptoms and illnesses associated with smoking behaviors.
Whether such uses were specifically intended for these agents is unknown. Our results provide a clear rationale for regulatory control of tobacco additives. ( Initially, we searched for documents about additives on the Indiana University list, as well as keywords such as "additive" and combinations of keywords such as "additive" and "environmental tobacco smoke." To further our understanding of the use of additives, we employed snowball sampling methods wherein the content of the documents we reviewed (e.g., names, references to other documents, and important concepts) would then be searched in the Legacy Library. We followed these document leads in an effort to better assess industry efforts associated with tobacco additives. In all, we reviewed more than 10 000 documents.
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RESULTS

Nicotine Metabolism and Addiction Potential
Numerous chemical agents, including gamma-heptalactone, gamma-valerolactone, gammadecalactone, delta-decalactone, gamma-dodecalactone, deltaundecalactone, and gammahexalactone, are mild to weak inhibitors of coumarin-7-hydroxylases (also known as CYP2A5 and CYP2A6; these are enzymes within the P450 enzyme system that metabolize compounds in the body). 32 These 7 chemicals are among those found on the additives list. Because CYP2A6 is involved in the metabolism of nicotine, the presence of these chemicals could decrease smokers' metabolism of nicotine and maintain higher blood levels (thus increasing smokers' exposure to nicotine by slowing degradation of nicotine in the bloodstream). Furthermore, the inhibitory effect of these chemicals on CYP2A6, although relatively weak in isolation, might be greater when the chemicals act in combination.
If nicotine were the only addictive chemical affecting smoking behavior, then puffing should decrease as the amount of inhaled nicotine increases. However, this hypothesis does not account for the effects of other addictive substances in cigarettes. Acetaldehyde is formed in high concentrations when cigarette constituents, including sugars, are burned. Animal research conducted by Philip Morris demonstrated a synergistic interaction between nicotine and acetaldehyde: rats pressed a bar more for the combination than for either substance alone. 33, 34 Sensory CSERP studies investigated whether given flavorants stimulated the olfactory nerve, the trigeminal nerve, or both. 38 Gullotta, one of the Philip Morris researchers, reported that CSERPs provided an objective measure of both impact and odor discrimination, in that different tobacco flavorants (e.g., natural vs synthetic menthol) affected CSERPs differently, even when smokers were unable to discriminate subjectively. 38 In effect, Philip Morris developed a putative method of objectively measuring and quantifying "impact." 40 
Addition of Antioxidants and Mitigants
RJ Reynolds investigated the addition of beta-carotene to cigarettes, including development of genetically engineered tobacco plants with genes inserted for beta-carotene production. RJ Reynolds's beta-carotene study group consisted of representatives from 15 different departments within RJ Reynolds. 
Genetic Modification of Tobacco
In addition to Brown and Williamson's efforts to genetically manipulate nicotine levels of cigarettes sold in the United States (which have been documented in the media 6 ), other companies in the industry also engaged in biotechnology development projects. Two examples were RJ Reynolds's development projects designed to incorporate the beta-carotene gene, control nicotine levels, and genetically modify the tobacco plant in other ways [97] [98] [99] [100] and Philip Morris's development of specific molecules (antisense RNA) to decrease carcinogenic tobaccospecific nitrosamines.
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Use of "Beneficial" Additives
A 1981 surgeon general's report, The Changing Cigarette, expressed concern about cigarette additives causing additional or new health care risks.
102(pp6,8,51-52,99-100) After the publication of that report, incorporation of "beneficial" additives into cigarettes was discussed at a pair of Philip Morris meetings in 1981. 103 In addition to scientists and other research and development personnel from Philip Morris, Hamish Maxwell, the CEO and president of Philip Morris, attended the meetings. The Philip Morris document summarizing these meetings defined "beneficial" as follows:
(1) "creating more profit (sales) to Philip Morris"; (2) "creating a positive public image"; (3) "being safe, good for you as well as pleasurable"; and (4) "creating a favorable image with government agencies." 103 The document also stated that "rather than deliver a physiological effect directly we might incorporate an additive which causes the body to produce its own physiological agent. Thus, we could alleviate pain, increase sex drive, etc., without adding agents to do this but by adding a naturally occurring promoter." 103 Moreover:
It was noted that one beneficial attribute ascribed to smoking is appetite suppressance [sic] . A thorough study of this effect and publication of the results may have a beneficial impact on the image of smoking. If particular compounds responsible for the effect can be found, it might be possible to enhance the effect in a cigarette aimed at people desiring help with weight control. Care must be taken not to make specific claims or to invoke a "drug additive" image. 103 Finally, according to the document:
Other factors were thought of (in addition to appetite suppression) that could be screened for beneficial effects of smoking. [64] [65] [66] [67] [68] Antimicrobial, increases lung mucociliary clearance, suppresses arachidonic acid metabolism and cytokine production in human monocytes, antiinflammatory activity in asthma patients; induction of apoptosis in human leukemia cell lines, antinocioceptive Metabolized by oxidation to salicylic acid. Promotes wound healing and granulation when applied topically, and was shown in a rat study to be a less potent analgesic and anti-inflammatory agent. Equipotent with salicylic acid, methyl salicylate, and aspirin in hindpaw edema assay; equipotent with aspirin in acute inflammation Tetrahydroquinolines, on the basis of experimental data, have been hypothesized to act as "false neurotransmitters" in catecholamine-containing neurons. In the 1960s, formaldehyde was shown to condense with endogenous catecholamines to form tetrahydroquinolines. That acetaldehyde is highly reactive with catecholamines was one of the reasons for DeNoble pursuing his research on the reinforcing effects of acetaldehyde. 91 Might serve as a "false neurotransmitter" 91 Flavorant. Also increases P 1 -N 2 amplitude, an objective CNS activity measure correlated with favorable sensory characteristics of cigarettes, subjectively experienced as similar to sugar
Note. CNS = central nervous system; RJR = RJ Reynolds. This is not an exhaustive list of specific chemical additives with pharmacological effects; rather, it represents selected examples of additives with possible pharmacological effects.
The idea again is to ascribe the effect to an additive that is already naturally occurring in tobacco, and then to possibly manipulate that additive: a) dental caries [tooth decay], b) reduction in constipation, c) heart rate regulation, d) effects in colds (i.e., mentholated brands), [and] e) anxiety reduction. 103 No information is available on the extent to which Philip Morris engaged in subsequent action to study or incorporate the "beneficial" additives discussed at these meetings.
A Isovaleric acid potentially acting as a pheromone influencing sexual behavior.
C, F, G, H Menthol and other specific additives function as local anesthetics to mask noxious sensory stimuli.
Theobromine from cocoa and chocolate, and glycyrrhizin and caffeine lead to bronchodilation, which enhances penetration of cigarette smoke into the lungs.
GVL and associated chemical additives decrease nicotine metabolism by inhibiting CYP 2A6 metabolism, thus maintaining a higher concentration of nicotine in the body.
Specific botanical and chemical additives, including antioxidants and mitigants, lead to decreased symptoms or mask the symptoms, possibly keeping people smoking longer while continuing to be exposed to, and to accumulate, harmful chemicals. The additives haven't been documented to improve health and, in the case of beta-carotene, have been shown to possibly increase lung cancer rates. Specific botanical and chemical additives may possibly function as anesthetic, anitbacterial, antifungal, anti-inflammatory, and antiviral agents.
AT, which includes reconstituted tobacco, NH 3 , NH 4 OH, other AT, tobacco essence to increase free base nicotine, and to have front-end lift. Increased free base nicotine may lead to increased distribution of nicotine in the lungs enabling nicotine to cross membranes faster, penetrate the CNS faster, and allow greater concentrations of nicotine to cross membranes at the lungs and the CNS, which could lead to possibly increased impact and addctive effect. Urea leads to ammonia release for AT.
DAP, MAP, levulinic acid, nicotine levulinate, glycerin to increase nicotine levels in smoke. DAP, PECTIN, and NH 4 OH formulas increase nicotine transfer into smoke.
Sugars, vanillin, ethyl vanillin, cocoa, and chocolate increase the sweet taste of cigarettes, enticing youths to smoke. Vanillin also has been documented to enhance objective EEG patterns associated with increased impact.
Per DeNoble studies, increased sugars lead to increased acetaldehyde via pyrolysis, which leads to increased pulmonary irritation, increased exposure to carcinogen, and increased CNS addiction. Levulinic acid and nicotine levulinate also increase nicotine binding to CNS receptors, leading to greater impact and increased addictive effect. Amadori compound formation via pyrolysis, and pyridine and tetrahydroquinoxaline additives could also possibly enhance addiction.
Note. ETS = environmental tobacco smoke; AT = ammonia technology; CNS = central nervous system; DAP = diammonium phosphate; MAP = monoammonium phosphate.
FIGURE 1-Summary of pharmacological and chemical effects of cigarette additives.
and the cost associated with purchasing niacin in lots of 5000 or more kilograms, 108 and studied naturally occurring rutin in cigarettes.
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The patent listed 33 botanicals or vegetable materials, or compounds within them, that also appear on the tobacco industry cigarette additive list, including beets, carrots, chamomile, corn, eucalyptus, maple and maple syrup, menthe piperita, oak, patchouli, rose, and vanilla plantifolia. In its discussion of cigarette casing material, the patent listed caramel, licorice root, niacin, rutin, and glycerol as possible additives and noted that the following aromatics, flavoring agents, sweeteners, coloring agents, and humectants could be added or substituted in a vegetable material preparation that would naturally contain niacin and rutin: sage, honey, sucrose, vanillin, coumarin, vanilla bean, fruit flavors, molasses, propylene glycol, apple juice, apple cider, essential oils, anise, angelica, and prune juice. It is noteworthy that so many botanical agents listed in the patent are also mentioned on the tobacco industry's list of additives. 
Other Specific Chemical Additives
Tobacco companies have added many other chemicals with a wide variety of possible effects (Figure 1) . Table 1 The tobacco industry's scientific efforts were far more advanced compared with public scientific efforts to understand nicotine addiction. Philip Morris's research into EEG, PREP, and CSERP shows that the tobacco company attempted to quantify "impact" and to monitor the neurological effects of specific additives to maximize "cigarette acceptance" (which encompasses factors such as cigarette "satisfaction" and is influenced by a number of elements, including primary reinforcement [e.g., nicotine addiction] and secondary reinforcement 115 ).
From a public health perspective, increasing the addictive potential of cigarettes with additives (e.g., via formulas including sugar, sorbitol, and DAP) increases the likelihood that new smokers will become addicted and that current smokers will have more difficulty quitting. Consequently, there will be greater levels of morbidity and mortality associated with smoking.
Masking and Treating Symptoms
The tobacco industry has stated that additives are used primarily for flavoring and "smoothing" the smoker's experience. However, a review of botanical medicine sources 103, 116 indicates that many botanical and phytochemical additives have other properties, including anesthetic, antibacterial, anticancer, antiinflammatory, antifungal, and antiviral properties. Industry documents 65, 104, [110] [111] [112] show awareness of and interest in these additional properties. Unregulated botanical and chemical additives might have "multiple use" purposes, such as enhancing flavor and providing for a "smoother" smoking experience as well as preventing or masking symptoms associated with illnesses induced by smoking. Because inclusion of botanical and chemical additives could reduce, mask, or prevent smokers' awareness of the adverse symptoms caused by smoking (e.g., cough), smokers might continue to smoke even when they are ill, preventing reductions in cigarette consumption and sales revenues. RJ Reynolds's addition of betacarotene to cigarettes suggests that adverse health effects can occur even when a seemingly benign additive is used and points to the need for regulation by the Food and Drug Administration. Although the actions of betacarotene and other additives may have decreased the carcinogenicity of cigarettes, their use may have unintentionally increased the risk for and rate of lung cancer in smokers.
A 1994 study concluded that there was no reduction in the incidence of lung cancer among male smokers after 5 to 8 years of oral supplementation with alpha-tocopherol or betacarotene. That study raised the possibility that oral beta-carotene supplements might actually have harmful effects in smokers and might increase lung cancer rates. 46 A newer study 117 also has documented the possible adverse effects of oral beta-carotene on lung cancer. This is an example of the potential occurrence of unwanted and unanticipated dangerous effects if appropriate regulatory agencies do not monitor the use of additives.
Unresolved Issues
The actual composition of extracts used, the parts of plants used, and the physiological and pathological effects of these additives are unknown. It is not clear whether sufficient amounts of pharmacologically active chemicals derived from these additives remain after pyrolysis; no information is available on the effects of combustion of these compounds in cigarettes at the concentrations used, let alone whether the combustion products actually have any of the listed properties in vivo when smoked. For example, only scientific experimentation will be able to reveal whether theobromine, glycyrrhizin, and other cigarette additives induce a bronchodilator effect.
Conclusions
Modern cigarettes have been extensively engineered and optimized as nicotine delivery devices developed through major national and international research and development programs. The aver-age smoker has been unaware of these efforts by the tobacco industry and of the extensive manipulation of cigarette chemistry.
Our results indicate that more than 100 of 599 documented cigarette additives have pharmacological actions. Previous research 18, 21, 22 has documented extensive efforts by the tobacco industry to use additives to mask the presence of ETS by reducing the visibility, odor, and irritability of tobacco smoke. Similar to the findings of previous studies, our results show that the tobacco industry used additives (1) that enhance or maintain nicotine delivery and could increase the addictiveness of cigarettes and (2) that mask symptoms and illnesses associated with smoking behavior. To our knowledge, there has been no systematic evaluation of the public health effects of cigarette additives or their combustion products. The tobacco industry has actively manipulated cigarette content by using potentially hazardous chemical and phytochemical additives that should be regulated. Unregulated use of additives in tobacco products subjects billions of smokers and nonsmokers alike to an uncontrolled experiment with potentially devastating health effects. 
About the Authors
Contributors
M. Rabinoff was involved with all aspects of research, writing, and editing of the article. N. Caskey was involved in all aspects of editing and helped with research on many of the issues brought up during the review process. A. Rissling helped with most areas of research and did some writing for the initial version of the article. C. Park helped with research on numerous issues, especially on the topic of additives affecting environmental tobacco smoke.
